CLINICAL_TRIALS
trial_result
· 2022-04-14
Clinical Trial Update: Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection [Phase 3]
Summary
A Phase 3 trial evaluated nitazoxanide for efficacy and safety in treating colds caused by Enterovirus/Rhinovirus; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Romark Laboratories L.C. | Conditions: Enterovirus, Rhinovirus | Phase 3 | Status: COMPLETED | Results posted: 2022-04-14